LGALS9 and acute myeloid leukemia: Binding between Tim-3 on leukemic cells and its ligand galectin-9, which is highly expressed in AML blasts, promotes self-renewal via stimulatory β-catenin and NFkB-signaling, and reduces the release of pro-inflammatory cytokines resulting in NK- and T-cell dysfunction [32,33].